Publications
- Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation2012 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Intragraft cytomegalovirus infection: results of randomized trial of valacyclovir prophylaxis vs. preemptive valganciclovir therapy in renal transplant recipients2010 | Central Library of Charles University
- Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation2008 | Central Library of Charles University
- A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation2002 | Faculty of Medicine in Pilsen, Central Library of Charles University
- A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients2023 | Faculty of Medicine in Pilsen
- Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial2023 | Faculty of Medicine in Pilsen
- Vybrané doporučené postupy v nefrologii2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic2022 | Faculty of Medicine in Pilsen
- Doporučení pro léčbu COVID-19 u pacientů po transplantaci ledviny2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
Loading network view...